AstraZeneca in deal with Kangtai Bio to supply potential COVID-19 vaccine in China

  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 22 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 66%

Singapore Headlines News

Singapore Latest News,Singapore Headlines

AstraZeneca PLC has signed an exclusive framework agreement with China's Shenzhen Kangtai Biological Products to supply its COVID-19 vaccine ...

BEIJING: AstraZeneca has signed an exclusive framework agreement with China's Shenzhen Kangtai Biological Products to supply its COVID-19 vaccine candidate in mainland China, the British pharmaceutical giant said on Thursday .

To meet market demand in China, Shenzhen Kangtai is obliged to make sure it has an annual production capacity of at least 100 million doses of the experimental shot AZD1222 – which AstraZeneca co-developed with researchers at Oxford University – by the end of this year, and a capacity of at least 200 million doses by the end of next year, AstraZeneca said in a statement on the Chinese social media site WeChat.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in SG

Singapore Latest News, Singapore Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Moderna says discussing supply deals with countries for Covid-19 vaccineBANGALORE (REUTERS) - Moderna said on Wednesday (Aug 5) it has started talks with several countries for supply agreements for its experimental coronavirus vaccine and has received about US$400 million (S$548 million) in deposits for potential supply.. Read more at straitstimes.com.
Source: The Straits Times - 🏆 8. / 63 Read more »

Moderna says discussing supply deals with countries for COVID-19 vaccineModerna Inc said on Wednesday it has started talks with several countries for supply agreements for its experimental coronavirus vaccine and has ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Novavax signs COVID-19 vaccine supply deal with India's Serum InstituteNovavax Inc said on Wednesday it has entered a supply and license agreement with the Serum Institute of India for the development and ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Malaysia in talks with China over potential MOU for early access to COVID-19 vaccine: Science and technology ministerKUALA LUMPUR: Malaysia is in talks with China over a potential Memorandum of Understanding to ensure access to the COVID-19 vaccine when it is ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Pfizer announces deal with Canada for experimental COVID-19 vaccineOTTAWA: Pharmaceutical giant Pfizer and German biotech firm BioNTech on Wednesday (Aug 5) said they had signed a deal to supply Canada with an ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Human trials of COVID-19 vaccine set to begin in IndonesiaHuman trials on a potential coronavirus vaccine are due to start in Indonesia next week as part of a collaboration between state-owned ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »